[Skip to Navigation]
Sign In
Views 805
Citations 0
Comment & Response
November 4, 2020

Implications of Omitting Sentinel Lymph Node Biopsy in Patients Older Than 70 Years

Author Affiliations
  • 1Division of Surgical Oncology, Department of Surgery, The Ohio State University Wexner Medical Center, Columbus
  • 2Department of Radiation Oncology, The Ohio State University Wexner Medical Center, Columbus
JAMA Surg. 2021;156(2):199-200. doi:10.1001/jamasurg.2020.5008

To the Editor We read with great interest the article by Wang et al, wherein they reviewed 57 articles pertaining to the 4 low-value breast cancer (BC) operations defined by the Choosing Wisely campaign.1 We commend the authors for presenting opportunities for deimplementation of low-value procedures to reduce health care waste. However, with regards to omission of sentinel lymph node biopsy (SLNB) in elderly patients with stage I, estrogen-receptor positive BC (ER+BC), there are important caveats to consider.

Add or change institution
Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words
    ×